Trial intelligence / Profile preview

Remifentanil Effects on Breathing Pattern in Mechanically Ventilated Patients

NCT00665119Phase 4Completed

Sponsor
Fondazione Poliambulanza
Start
Apr 2008
Primary completion
Oct 2008
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of remifentanil in Respiratory Insufficiency (RI), sponsored by Fondazione Poliambulanza. Primary endpoints: Respiratory Rate/Tidal Volume Ratio and Pressure-Time Product. Started Apr 2008; status: completed.

02

Drugs

remifentanil
03

Conditions

Respiratory Insufficiency (RI)

Beyond the preview

Go deeper on NCT00665119.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00665119.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call